This multifaceted interaction underpins their significant therapeutic potential in cancer (inhibiting growth, survival, metastasis), fibrosis (modulating TGF-β), inflammation (targeting NF-κB, JAK/STAT), and immune regulation. The gene discussed is TGFB1; the disease is cancer.